glp-1 agonists addiction Drugs: A Game Changer for Recovery? Substance use disorders (SUDs) may

With the rising incidence of obesity, there is a growing demand for new therapies which can effectively manage body weight and improve health

The mechanisms underlying these effects involve the modulation of signaling pathways associated with cell growth, survival, and metabolism

The science behind 24% weight loss results explained.

Ascletis ASC35, a once-monthly GLP-1/GIP peptide using a self-assembling lipid depot, cleared FDA IND for Phase 1 head-to-head vs weekly tirzepatide June 23.

Youve likely heard about glucagon-like peptide-1 agonists commonly referred to as GLP-1 medications, and more widely recognized through pharmaceutical brand names like Ozempic and Mounjaro.

Initially developed to improve glycemic control, these agents are now recognized as important components of cardiovascular risk reduction strategies